| Code | Description | Claims | Beneficiaries | Total Paid |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
495,590 |
414,086 |
$72.38M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
117,580 |
106,439 |
$18.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
87,551 |
77,662 |
$17.12M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
108,518 |
100,728 |
$17.12M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
95,197 |
86,886 |
$13.28M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
37,935 |
25,733 |
$11.77M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
235,418 |
189,958 |
$7.68M |
| 99215 |
Prolong outpt/office vis |
41,112 |
34,276 |
$6.21M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
83,650 |
27,258 |
$5.25M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29,448 |
22,371 |
$5.16M |
| 96415 |
|
9,844 |
7,511 |
$5.14M |
| 59025 |
Fetal non-stress test |
19,842 |
13,001 |
$4.81M |
| G0378 |
Hospital observation service, per hour |
38,459 |
35,398 |
$4.69M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,056 |
35,039 |
$4.61M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
24,823 |
14,969 |
$4.41M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,527 |
5,325 |
$3.92M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
2,406 |
2,088 |
$3.50M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
55,597 |
48,161 |
$3.44M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
12,645 |
8,551 |
$3.42M |
| S9485 |
Crisis intervention mental health services, per diem |
8,513 |
5,657 |
$3.40M |
| 70450 |
Computed tomography, head or brain; without contrast material |
24,049 |
22,201 |
$3.04M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
23,005 |
21,744 |
$3.00M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
51,190 |
41,988 |
$2.76M |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
24,289 |
23,150 |
$2.65M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
23,228 |
22,002 |
$2.32M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,530 |
2,488 |
$2.24M |
| 95811 |
|
3,134 |
3,070 |
$2.21M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
1,199 |
1,145 |
$2.17M |
| J9271 |
Injection, pembrolizumab, 1 mg |
216 |
168 |
$2.05M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
11,088 |
10,877 |
$2.05M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
16,864 |
16,692 |
$1.90M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46,204 |
41,350 |
$1.86M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
19,052 |
18,994 |
$1.81M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,872 |
2,747 |
$1.81M |
| 95806 |
|
2,806 |
2,782 |
$1.80M |
| 93971 |
|
9,678 |
9,159 |
$1.78M |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
26,955 |
26,427 |
$1.77M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
18,363 |
18,320 |
$1.73M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
13,492 |
12,250 |
$1.70M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
26,490 |
24,235 |
$1.60M |
| 58661 |
|
471 |
468 |
$1.60M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12,288 |
11,881 |
$1.53M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
69,767 |
49,099 |
$1.50M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,380 |
1,299 |
$1.49M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59,051 |
56,841 |
$1.47M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
58,742 |
56,558 |
$1.47M |
| J2357 |
Injection, omalizumab, 5 mg |
4,068 |
1,861 |
$1.46M |
| 76770 |
|
9,169 |
8,843 |
$1.45M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14,033 |
12,239 |
$1.44M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,028 |
9,603 |
$1.40M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14,643 |
14,594 |
$1.39M |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14,673 |
14,480 |
$1.26M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
13,779 |
7,089 |
$1.25M |
| 62323 |
|
3,332 |
3,229 |
$1.24M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
9,152 |
9,028 |
$1.21M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
6,533 |
4,126 |
$1.19M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
252,214 |
205,432 |
$1.17M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
4,434 |
4,290 |
$1.16M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,191 |
3,082 |
$1.14M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,331 |
2,218 |
$1.11M |
| 97161 |
|
16,099 |
15,382 |
$1.11M |
| 76642 |
|
10,109 |
9,798 |
$1.11M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
58,342 |
51,692 |
$1.10M |
| 93458 |
|
1,173 |
1,146 |
$1.09M |
| 87631 |
|
13,958 |
13,603 |
$1.08M |
| 76830 |
Ultrasound, transvaginal |
10,609 |
10,311 |
$1.07M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15,121 |
13,974 |
$1.03M |
| 43235 |
|
1,617 |
1,517 |
$982K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,653 |
8,278 |
$980K |
| 93308 |
|
5,124 |
4,911 |
$979K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,619 |
2,499 |
$964K |
| 96367 |
|
5,413 |
3,870 |
$953K |
| 93970 |
|
4,302 |
4,155 |
$940K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
3,316 |
432 |
$931K |
| 95886 |
|
4,405 |
4,257 |
$909K |
| 71046 |
Radiologic examination, chest; 2 views |
66,337 |
61,289 |
$906K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,506 |
3,407 |
$897K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,606 |
5,323 |
$893K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,945 |
4,684 |
$832K |
| 70496 |
|
4,606 |
4,393 |
$812K |
| 76801 |
|
7,285 |
6,829 |
$801K |
| 36430 |
|
2,945 |
2,038 |
$789K |
| 84443 |
Thyroid stimulating hormone (TSH) |
79,257 |
75,279 |
$771K |
| 93975 |
|
10,164 |
9,697 |
$757K |
| 90834 |
Psychotherapy, 45 minutes with patient |
9,936 |
6,242 |
$750K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
20,949 |
8,859 |
$728K |
| 97162 |
|
11,587 |
11,138 |
$703K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,973 |
4,893 |
$700K |
| 64415 |
|
1,708 |
1,588 |
$700K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28,612 |
28,067 |
$681K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,479 |
1,059 |
$672K |
| 93798 |
|
15,150 |
3,530 |
$661K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,409 |
2,406 |
$656K |
| 87481 |
|
14,187 |
12,594 |
$646K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
8,219 |
8,069 |
$644K |
| 76536 |
|
5,220 |
5,135 |
$603K |
| 93325 |
|
5,973 |
5,773 |
$599K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
33,670 |
33,053 |
$593K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
9,671 |
8,664 |
$579K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,827 |
5,416 |
$572K |
| 94060 |
|
5,351 |
5,251 |
$569K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
8,615 |
8,202 |
$567K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
1,610 |
1,068 |
$566K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
20,484 |
19,628 |
$547K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
194 |
184 |
$546K |
| 76813 |
|
4,243 |
4,181 |
$533K |
| 97803 |
|
7,359 |
6,967 |
$532K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
6,177 |
3,834 |
$531K |
| 97802 |
|
7,143 |
7,027 |
$529K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
9,517 |
9,413 |
$524K |
| 54161 |
|
296 |
295 |
$517K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
61,952 |
53,047 |
$506K |
| 81513 |
|
7,246 |
6,788 |
$502K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
3,059 |
3,019 |
$492K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
114,505 |
112,133 |
$488K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,060 |
2,023 |
$484K |
| 80051 |
|
110,577 |
86,485 |
$461K |
| 19083 |
|
354 |
350 |
$440K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,458 |
1,401 |
$438K |
| 90686 |
|
52,511 |
51,632 |
$431K |
| 12011 |
|
1,835 |
1,804 |
$425K |
| 95708 |
|
1,147 |
930 |
$419K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
83,471 |
80,978 |
$418K |
| 90715 |
|
20,992 |
20,739 |
$417K |
| 99201 |
|
2,921 |
2,836 |
$416K |
| 76942 |
|
8,792 |
8,241 |
$413K |
| 80053 |
Comprehensive metabolic panel |
90,869 |
83,933 |
$406K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
24,134 |
23,482 |
$405K |
| 12001 |
|
1,832 |
1,804 |
$404K |
| 71250 |
|
5,586 |
5,421 |
$399K |
| 83880 |
|
23,551 |
21,341 |
$399K |
| 84484 |
|
59,021 |
45,251 |
$399K |
| 93304 |
|
1,424 |
1,391 |
$398K |
| 99381 |
|
3,027 |
2,925 |
$391K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
18,247 |
18,040 |
$389K |
| 96402 |
|
694 |
664 |
$387K |
| 95953 |
|
562 |
473 |
$384K |
| 77412 |
|
2,490 |
266 |
$381K |
| 85027 |
|
90,330 |
79,692 |
$371K |
| 93017 |
|
4,502 |
4,389 |
$367K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
55,840 |
40,036 |
$366K |
| 58300 |
|
1,407 |
1,398 |
$366K |
| 77336 |
|
5,566 |
2,349 |
$363K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
855 |
832 |
$360K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
6,439 |
5,791 |
$350K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
59,656 |
54,925 |
$340K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14,748 |
14,527 |
$337K |
| 90791 |
Psychiatric diagnostic evaluation |
2,573 |
2,362 |
$337K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,445 |
1,371 |
$335K |
| 97597 |
|
6,382 |
3,931 |
$326K |
| 97165 |
|
3,404 |
3,298 |
$322K |
| 77065 |
Tomosynthesis, mammo |
6,556 |
6,254 |
$321K |
| 92587 |
|
2,684 |
2,666 |
$311K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
117,991 |
103,018 |
$308K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,675 |
2,475 |
$305K |
| 20552 |
|
1,536 |
1,460 |
$292K |
| 74183 |
|
717 |
689 |
$288K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,821 |
1,817 |
$283K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
80,882 |
71,462 |
$280K |
| 83605 |
|
38,376 |
33,314 |
$280K |
| 72100 |
|
7,830 |
7,590 |
$278K |
| 86780 |
|
27,186 |
26,342 |
$278K |
| 87536 |
|
6,143 |
5,981 |
$275K |
| 76870 |
|
2,765 |
2,635 |
$275K |
| 20610 |
|
1,650 |
1,511 |
$274K |
| V5160 |
Dispensing fee, binaural |
676 |
610 |
$274K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
10,055 |
8,260 |
$270K |
| 88307 |
|
3,334 |
3,180 |
$267K |
| V5261 |
Hearing aid, digital, binaural, bte |
526 |
477 |
$266K |
| 81025 |
|
43,959 |
41,911 |
$257K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,670 |
3,327 |
$256K |
| 94726 |
|
5,473 |
5,343 |
$253K |
| 95782 |
|
237 |
236 |
$248K |
| V5266 |
Battery for use in hearing device |
4,029 |
3,772 |
$247K |
| 64445 |
|
999 |
971 |
$247K |
| 87088 |
|
29,640 |
21,383 |
$246K |
| 94729 |
|
5,473 |
5,386 |
$242K |
| 86481 |
|
4,589 |
4,495 |
$241K |
| 86480 |
|
5,569 |
5,464 |
$235K |
| 77061 |
|
2,283 |
2,270 |
$224K |
| 93922 |
|
4,151 |
4,054 |
$222K |
| 86803 |
|
22,761 |
22,329 |
$221K |
| 44970 |
|
65 |
65 |
$220K |
| 77386 |
|
1,065 |
87 |
$217K |
| 64721 |
|
291 |
271 |
$217K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,768 |
1,165 |
$216K |
| 94375 |
|
4,135 |
3,978 |
$216K |
| 58301 |
|
850 |
842 |
$209K |
| 84702 |
|
18,298 |
16,426 |
$207K |
| 81001 |
|
98,521 |
89,732 |
$206K |
| 82565 |
|
125,656 |
99,678 |
$204K |
| 77062 |
|
2,078 |
2,074 |
$203K |
| 77080 |
|
4,404 |
4,301 |
$200K |
| 11982 |
|
888 |
883 |
$196K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
37,553 |
33,205 |
$192K |
| 83690 |
|
43,103 |
38,855 |
$191K |
| Q3014 |
Telehealth originating site facility fee |
46,683 |
40,376 |
$188K |
| 74018 |
|
7,740 |
7,220 |
$187K |
| 86850 |
|
29,711 |
27,430 |
$186K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
243 |
89 |
$186K |
| 92552 |
|
6,977 |
6,940 |
$182K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,870 |
15,248 |
$182K |
| 0001A |
|
6,021 |
5,785 |
$176K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
1,999 |
1,979 |
$173K |
| 83735 |
|
47,930 |
36,683 |
$173K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,426 |
7,180 |
$171K |
| 76882 |
|
1,450 |
1,420 |
$168K |
| 87653 |
|
5,668 |
5,521 |
$167K |
| 0002A |
|
5,615 |
5,414 |
$166K |
| 72141 |
|
561 |
552 |
$164K |
| 97014 |
|
1,896 |
810 |
$163K |
| 82728 |
|
20,366 |
19,635 |
$163K |
| 97035 |
|
2,489 |
1,016 |
$160K |
| 27447 |
|
28 |
26 |
$158K |
| 73630 |
|
8,133 |
7,857 |
$158K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
27,633 |
25,299 |
$157K |
| 12002 |
|
699 |
685 |
$156K |
| 20553 |
|
683 |
588 |
$155K |
| 83655 |
|
13,501 |
13,399 |
$154K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
15,667 |
7,891 |
$154K |
| 64615 |
|
513 |
466 |
$152K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,682 |
1,325 |
$152K |
| 73130 |
|
7,909 |
7,554 |
$151K |
| 97166 |
|
1,538 |
1,482 |
$148K |
| 11981 |
|
488 |
485 |
$148K |
| 93225 |
|
2,791 |
2,732 |
$147K |
| 73030 |
|
7,855 |
7,489 |
$146K |
| 73560 |
|
8,832 |
8,452 |
$146K |
| 70491 |
|
1,035 |
998 |
$144K |
| 51725 |
|
488 |
472 |
$144K |
| 73610 |
|
7,872 |
7,532 |
$143K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,427 |
4,095 |
$143K |
| 93880 |
|
2,425 |
2,365 |
$142K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
216 |
216 |
$141K |
| 96523 |
|
3,430 |
2,452 |
$140K |
| 92523 |
|
1,050 |
1,040 |
$140K |
| 72040 |
|
3,582 |
3,448 |
$140K |
| 87040 |
|
17,982 |
11,803 |
$138K |
| 82607 |
|
17,117 |
16,656 |
$136K |
| 84439 |
|
24,464 |
23,494 |
$136K |
| 84520 |
|
110,468 |
89,490 |
$136K |
| 80061 |
Lipid panel |
35,083 |
34,226 |
$136K |
| 99383 |
|
1,368 |
1,355 |
$135K |
| 47562 |
|
37 |
36 |
$134K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
181 |
181 |
$134K |
| 71045 |
Radiologic examination, chest; single view |
20,796 |
18,851 |
$133K |
| 84703 |
|
24,358 |
22,494 |
$133K |
| 76825 |
|
1,087 |
1,049 |
$130K |
| J1644 |
Injection, heparin sodium, per 1000 units |
21,332 |
11,752 |
$129K |
| ATP14 |
|
19,110 |
15,552 |
$128K |
| 64447 |
|
835 |
815 |
$127K |
| 90651 |
|
11,107 |
11,080 |
$126K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
65,124 |
55,176 |
$125K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
30,871 |
23,733 |
$125K |
| 99385 |
|
1,323 |
1,320 |
$124K |
| J2704 |
Injection, propofol, 10 mg |
54,474 |
50,103 |
$123K |
| 95816 |
|
387 |
387 |
$121K |
| J0485 |
Injection, belatacept, 1 mg |
455 |
217 |
$121K |
| 87340 |
|
16,618 |
16,179 |
$120K |
| 87522 |
Neg quan hep c or qual rna |
3,997 |
3,899 |
$120K |
| 90662 |
|
4,351 |
4,163 |
$118K |
| 90674 |
|
5,525 |
5,483 |
$115K |
| 71271 |
|
2,824 |
2,752 |
$115K |
| 82947 |
|
79,200 |
69,960 |
$114K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,789 |
3,611 |
$113K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
111 |
111 |
$110K |
| 77300 |
|
869 |
780 |
$110K |
| 77066 |
Tomosynthesis, mammo |
3,972 |
3,873 |
$109K |
| 70498 |
|
4,458 |
4,263 |
$108K |
| 76775 |
|
1,378 |
1,334 |
$108K |
| 87081 |
|
18,549 |
18,032 |
$107K |
| 76604 |
|
1,257 |
1,209 |
$107K |
| 58558 |
|
58 |
57 |
$105K |
| 86140 |
|
26,473 |
24,680 |
$103K |
| 84460 |
|
62,434 |
55,662 |
$103K |
| ATP08 |
|
17,453 |
13,560 |
$102K |
| 90677 |
|
4,358 |
4,310 |
$101K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
40,445 |
38,251 |
$100K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
23,875 |
22,656 |
$99K |
| 69209 |
|
1,404 |
1,322 |
$98K |
| 86923 |
|
2,144 |
1,732 |
$97K |
| 20680 |
|
82 |
79 |
$97K |
| 88342 |
|
4,728 |
4,402 |
$96K |
| 10060 |
|
545 |
539 |
$95K |
| 73110 |
|
5,049 |
4,782 |
$95K |
| 86003 |
|
1,569 |
1,489 |
$94K |
| 86762 |
|
8,000 |
7,811 |
$94K |
| 76820 |
|
1,907 |
991 |
$94K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
10,329 |
9,586 |
$93K |
| 84450 |
|
57,824 |
51,348 |
$93K |
| 92567 |
|
3,257 |
3,206 |
$93K |
| 29824 |
|
94 |
88 |
$93K |
| 99384 |
|
932 |
929 |
$93K |
| 90837 |
Psychotherapy, 53 minutes with patient |
934 |
720 |
$92K |
| 86360 |
|
4,242 |
4,169 |
$91K |
| 73502 |
|
4,724 |
4,519 |
$89K |
| 70486 |
|
2,350 |
2,264 |
$87K |
| 64493 |
|
139 |
133 |
$87K |
| 87186 |
|
15,172 |
14,388 |
$87K |
| 85610 |
|
46,213 |
33,603 |
$87K |
| 83970 |
|
5,212 |
4,978 |
$87K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,563 |
1,520 |
$87K |
| 73562 |
|
2,552 |
2,515 |
$85K |
| 27130 |
|
13 |
13 |
$84K |
| V5264 |
Ear mold/insert, not disposable, any type |
1,076 |
990 |
$84K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
37 |
36 |
$83K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
24,816 |
15,193 |
$83K |
| 57454 |
|
226 |
225 |
$82K |
| 99188 |
|
6,139 |
6,105 |
$81K |
| ATP07 |
|
12,573 |
9,891 |
$81K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30,884 |
27,053 |
$81K |
| 76885 |
|
550 |
548 |
$80K |
| 76857 |
|
898 |
876 |
$80K |
| 92250 |
|
7,197 |
7,135 |
$78K |
| 83550 |
|
15,891 |
15,397 |
$78K |
| 82570 |
|
29,748 |
27,471 |
$78K |
| 90670 |
|
16,144 |
15,988 |
$77K |
| 74220 |
|
1,187 |
1,176 |
$77K |
| 97016 |
|
959 |
391 |
$77K |
| 83013 |
|
1,481 |
1,465 |
$76K |
| 93926 |
|
529 |
514 |
$75K |
| 64450 |
|
400 |
381 |
$75K |
| 96368 |
|
2,545 |
1,726 |
$74K |
| 86355 |
|
4,250 |
4,178 |
$74K |
| 86357 |
|
4,237 |
4,166 |
$73K |
| 86359 |
|
4,232 |
4,161 |
$73K |
| 94660 |
|
723 |
433 |
$72K |
| 86317 |
|
6,733 |
6,555 |
$72K |
| 90732 |
|
2,663 |
2,577 |
$71K |
| 82330 |
|
9,864 |
7,758 |
$70K |
| G0008 |
Administration of influenza virus vaccine |
10,179 |
9,558 |
$70K |
| 87486 |
|
2,823 |
2,732 |
$70K |
| 80305 |
|
10,530 |
7,372 |
$70K |
| 87581 |
|
2,828 |
2,735 |
$70K |
| 93226 |
|
2,815 |
2,755 |
$69K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42,132 |
38,310 |
$69K |
| 88341 |
|
1,635 |
1,475 |
$69K |
| 86900 |
|
27,106 |
24,909 |
$68K |
| 82784 |
|
9,129 |
7,930 |
$68K |
| 92550 |
|
903 |
888 |
$67K |
| 82247 |
|
43,681 |
37,668 |
$67K |
| 29826 |
|
94 |
94 |
$65K |
| 83540 |
|
17,529 |
16,974 |
$65K |
| 83021 |
|
4,172 |
4,073 |
$64K |
| 83718 |
|
11,567 |
11,406 |
$64K |
| 86787 |
|
6,000 |
5,858 |
$64K |
| 82746 |
|
7,954 |
7,731 |
$63K |
| 87210 |
|
15,523 |
11,933 |
$63K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16,753 |
11,240 |
$63K |
| 92557 |
|
1,259 |
1,225 |
$62K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
44,822 |
44,402 |
$62K |
| 76827 |
|
1,055 |
1,021 |
$62K |
| 80076 |
|
18,850 |
17,643 |
$61K |
| 17250 |
|
502 |
409 |
$61K |
| 0124A |
|
2,450 |
2,367 |
$59K |
| 87480 |
|
3,882 |
3,778 |
$58K |
| 77334 |
|
383 |
316 |
$58K |
| 29125 |
|
375 |
339 |
$58K |
| 93296 |
|
2,073 |
2,046 |
$58K |
| 87510 |
|
3,880 |
3,775 |
$58K |
| 87660 |
|
3,866 |
3,764 |
$57K |
| 84403 |
|
3,217 |
3,091 |
$57K |
| 87070 |
|
9,486 |
8,879 |
$56K |
| 64417 |
|
129 |
125 |
$54K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12,747 |
9,190 |
$54K |
| 0054A |
|
1,822 |
1,767 |
$54K |
| 82043 |
|
20,662 |
19,897 |
$54K |
| 85730 |
|
15,887 |
14,483 |
$54K |
| 85379 |
|
8,747 |
8,229 |
$53K |
| 86901 |
|
27,016 |
24,904 |
$53K |
| 84075 |
|
33,297 |
30,084 |
$52K |
| 95910 |
|
966 |
944 |
$51K |
| 90480 |
|
1,276 |
1,273 |
$51K |
| 83516 |
|
4,191 |
3,700 |
$51K |
| 73140 |
|
2,010 |
1,953 |
$50K |
| 90746 |
|
2,200 |
2,156 |
$50K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
30 |
30 |
$50K |
| 82105 |
|
3,550 |
3,480 |
$49K |
| 36415 |
Collection of venous blood by venipuncture |
164,644 |
142,180 |
$48K |
| 73080 |
|
3,680 |
3,494 |
$48K |
| 91320 |
|
904 |
902 |
$47K |
| 86704 |
|
6,444 |
6,267 |
$46K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,059 |
737 |
$46K |
| 85652 |
|
24,398 |
23,108 |
$45K |
| 19081 |
|
43 |
41 |
$45K |
| 75574 |
|
363 |
345 |
$44K |
| 72072 |
|
1,316 |
1,288 |
$44K |
| 80050 |
General health panel |
2,774 |
2,754 |
$44K |
| 87147 |
|
10,251 |
9,711 |
$43K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
7,269 |
6,896 |
$43K |
| 0004A |
|
1,681 |
1,622 |
$43K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
334 |
328 |
$43K |
| 96118 |
|
93 |
93 |
$43K |
| 99382 |
|
463 |
458 |
$43K |
| ATP11 |
|
7,026 |
5,547 |
$42K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
21 |
14 |
$42K |
| 97012 |
|
576 |
226 |
$41K |
| 81003 |
|
26,690 |
24,543 |
$41K |
| 74240 |
|
221 |
221 |
$41K |
| 82803 |
|
2,623 |
2,338 |
$40K |
| 49083 |
|
90 |
51 |
$40K |
| 10005 |
|
118 |
116 |
$40K |
| 52356 |
|
14 |
13 |
$40K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
116 |
49 |
$40K |
| 84146 |
|
2,689 |
2,644 |
$39K |
| ATP15 |
|
5,788 |
4,700 |
$39K |
| 74174 |
|
350 |
335 |
$39K |
| 87529 |
|
1,020 |
973 |
$38K |
| 87077 |
|
10,204 |
9,413 |
$37K |
| 58100 |
|
134 |
132 |
$36K |
| 95819 |
|
116 |
115 |
$36K |
| 92579 |
|
856 |
850 |
$35K |
| 83001 |
|
2,334 |
2,308 |
$34K |
| 96040 |
|
1,050 |
977 |
$33K |
| 0071A |
|
725 |
722 |
$33K |
| 84153 |
|
3,791 |
3,635 |
$33K |
| 54150 |
|
15 |
15 |
$32K |
| ATP17 |
|
6,185 |
4,499 |
$31K |
| 73590 |
|
3,547 |
3,383 |
$31K |
| 74230 |
|
214 |
212 |
$30K |
| 90656 |
|
2,564 |
2,539 |
$30K |
| 83721 |
|
6,895 |
6,473 |
$30K |
| J3490 |
Unclassified drugs |
10,498 |
7,014 |
$30K |
| 82465 |
|
12,154 |
11,972 |
$30K |
| 82950 |
|
7,078 |
6,995 |
$30K |
| 96411 |
|
1,800 |
1,100 |
$30K |
| 97116 |
|
927 |
548 |
$29K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
309 |
67 |
$29K |
| 86618 |
|
2,353 |
2,301 |
$28K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,119 |
2,059 |
$27K |
| 42830 |
|
13 |
13 |
$27K |
| 27096 |
|
65 |
65 |
$27K |
| 81508 |
|
1,515 |
1,366 |
$27K |
| 0072A |
|
631 |
630 |
$27K |
| 82670 |
|
1,236 |
1,206 |
$27K |
| 87902 |
|
241 |
239 |
$26K |
| 86038 |
|
3,106 |
3,067 |
$26K |
| 0031A |
|
883 |
775 |
$26K |
| ATP06 |
|
4,459 |
3,075 |
$26K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
22,665 |
16,436 |
$25K |
| 58340 |
|
37 |
37 |
$25K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
927 |
886 |
$25K |
| 90734 |
|
8,665 |
8,634 |
$25K |
| 49450 |
|
69 |
63 |
$25K |
| 82962 |
|
69,771 |
46,987 |
$24K |
| 93797 |
|
772 |
422 |
$24K |
| 84100 |
|
18,871 |
13,855 |
$24K |
| 90714 |
|
963 |
961 |
$23K |
| 82550 |
|
10,442 |
9,179 |
$23K |
| 88173 |
|
707 |
672 |
$23K |
| 95885 |
|
87 |
85 |
$23K |
| 87205 |
|
7,741 |
7,285 |
$22K |
| ATP09 |
|
3,704 |
2,614 |
$22K |
| 77002 |
|
264 |
245 |
$22K |
| 72170 |
|
1,810 |
1,709 |
$22K |
| 84481 |
|
1,972 |
1,882 |
$22K |
| J2182 |
Injection, mepolizumab, 1 mg |
26 |
24 |
$22K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12,055 |
11,640 |
$22K |
| 86708 |
|
2,751 |
2,701 |
$22K |
| 97535 |
Self-care/home management training, each 15 minutes |
401 |
278 |
$22K |
| 96417 |
|
5,668 |
3,461 |
$22K |
| 93923 |
|
251 |
247 |
$21K |
| 83002 |
|
1,483 |
1,458 |
$21K |
| 94664 |
|
1,893 |
1,834 |
$21K |
| 80179 |
|
2,749 |
2,507 |
$21K |
| 84163 |
|
1,671 |
1,649 |
$21K |
| 82150 |
|
4,894 |
4,615 |
$21K |
| 84156 |
|
9,803 |
8,480 |
$21K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
3,250 |
2,336 |
$21K |
| 0052A |
|
537 |
533 |
$21K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
878 |
473 |
$20K |
| 96416 |
|
157 |
99 |
$20K |
| 80074 |
|
679 |
659 |
$20K |
| 29881 |
|
12 |
12 |
$20K |
| 86665 |
|
1,101 |
726 |
$20K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
130 |
126 |
$20K |
| 82010 |
|
3,659 |
3,281 |
$19K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
5,306 |
3,452 |
$19K |
| 81002 |
|
7,109 |
6,065 |
$19K |
| 80164 |
|
2,762 |
2,521 |
$19K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,828 |
3,360 |
$19K |
| ATP10 |
|
4,506 |
3,720 |
$19K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
127 |
124 |
$18K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
65 |
65 |
$18K |
| 72131 |
|
690 |
667 |
$18K |
| 88112 |
|
517 |
429 |
$18K |
| 99218 |
|
750 |
700 |
$18K |
| 80047 |
|
6,143 |
4,610 |
$17K |
| 88304 |
|
5,670 |
5,410 |
$17K |
| ATP03 |
|
6,644 |
5,266 |
$17K |
| 82785 |
|
1,428 |
1,386 |
$17K |
| 84270 |
|
1,142 |
1,112 |
$17K |
| 86334 |
|
1,992 |
1,809 |
$17K |
| 97804 |
|
281 |
117 |
$16K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
716 |
546 |
$16K |
| 96133 |
|
76 |
72 |
$16K |
| 86765 |
|
1,665 |
1,648 |
$16K |
| 93978 |
|
341 |
327 |
$16K |
| ATP04 |
|
3,215 |
2,547 |
$15K |
| 82378 |
|
1,492 |
1,361 |
$15K |
| 87075 |
|
2,526 |
2,342 |
$15K |
| 77290 |
|
49 |
42 |
$15K |
| 73090 |
|
2,699 |
2,506 |
$15K |
| 85045 |
|
5,079 |
4,377 |
$15K |
| 10022 |
|
45 |
36 |
$14K |
| V5267 |
Hearing aid or assistive listening device/supplies/accessories, not otherwise specified |
1,559 |
1,497 |
$14K |
| 86735 |
|
1,432 |
1,415 |
$14K |
| 0051A |
|
361 |
360 |
$14K |
| ATP02 |
|
3,954 |
3,292 |
$14K |
| 86580 |
|
596 |
587 |
$13K |
| 82248 |
|
10,662 |
9,628 |
$13K |
| 96139 |
|
87 |
85 |
$13K |
| J3489 |
Injection, zoledronic acid, 1 mg |
556 |
518 |
$13K |
| 82040 |
|
8,366 |
7,737 |
$13K |
| 84132 |
|
8,841 |
7,756 |
$13K |
| 82310 |
|
8,509 |
7,277 |
$13K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,073 |
1,919 |
$13K |
| 83615 |
|
7,554 |
6,631 |
$13K |
| 83520 |
|
1,155 |
1,107 |
$13K |
| 95700 |
|
689 |
629 |
$12K |
| 87046 |
|
809 |
684 |
$12K |
| 51784 |
|
77 |
73 |
$12K |
| J2060 |
Injection, lorazepam, 2 mg |
10,362 |
8,397 |
$12K |
| 90707 |
|
4,894 |
4,888 |
$12K |
| 95912 |
|
149 |
143 |
$12K |
| 85014 |
|
8,107 |
7,270 |
$12K |
| 86376 |
|
1,139 |
1,120 |
$11K |
| 90632 |
|
3,575 |
3,571 |
$11K |
| 87507 |
|
31 |
30 |
$11K |
| 87517 |
|
485 |
475 |
$11K |
| 82274 |
|
1,563 |
1,524 |
$11K |
| 96401 |
|
86 |
62 |
$11K |
| 74019 |
|
600 |
571 |
$11K |
| 90649 |
|
861 |
855 |
$11K |
| 85018 |
|
5,586 |
5,284 |
$10K |
| 82140 |
|
1,364 |
1,251 |
$10K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
1,436 |
1,392 |
$10K |
| 92611 |
|
156 |
156 |
$10K |
| 77072 |
|
116 |
116 |
$10K |
| J1630 |
Injection, haloperidol, up to 5 mg |
8,774 |
7,722 |
$10K |
| 86664 |
|
739 |
726 |
$10K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
88 |
52 |
$10K |
| 11721 |
|
280 |
279 |
$10K |
| 90716 |
|
4,627 |
4,622 |
$10K |
| 77280 |
|
89 |
75 |
$9K |
| 77295 |
|
12 |
12 |
$9K |
| 80069 |
|
5,386 |
4,968 |
$9K |
| 84550 |
|
6,857 |
6,310 |
$9K |
| Q0114 |
Fern test |
1,702 |
1,590 |
$9K |
| 72158 |
|
55 |
53 |
$9K |
| 82652 |
|
454 |
435 |
$9K |
| 72050 |
|
168 |
168 |
$9K |
| 92558 |
|
65 |
65 |
$9K |
| 83014 |
|
1,464 |
1,447 |
$9K |
| 86304 |
|
887 |
786 |
$9K |
| 62322 |
|
13 |
13 |
$9K |
| 83883 |
|
1,186 |
1,049 |
$8K |
| 64405 |
|
26 |
24 |
$8K |
| 96132 |
|
88 |
84 |
$8K |
| 86431 |
|
2,048 |
2,034 |
$8K |
| 82553 |
|
1,644 |
1,465 |
$8K |
| 80177 |
|
965 |
906 |
$8K |
| 80143 |
|
2,079 |
1,800 |
$8K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
519 |
484 |
$8K |
| 84436 |
|
2,516 |
2,044 |
$8K |
| 86160 |
|
666 |
540 |
$8K |
| ATP12 |
|
1,329 |
1,006 |
$8K |
| 84295 |
|
5,685 |
5,095 |
$8K |
| 75561 |
|
27 |
27 |
$8K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
205 |
198 |
$8K |
| 99386 |
|
82 |
82 |
$8K |
| 82627 |
|
442 |
430 |
$7K |
| ATP05 |
|
1,351 |
1,068 |
$7K |
| 82533 |
|
581 |
530 |
$7K |
| 76937 |
|
407 |
376 |
$7K |
| 86706 |
|
1,022 |
1,002 |
$7K |
| 73552 |
|
1,061 |
1,003 |
$7K |
| 86235 |
|
276 |
227 |
$7K |
| 0003A |
|
423 |
414 |
$7K |
| 86677 |
|
677 |
663 |
$7K |
| 90739 |
|
106 |
106 |
$7K |
| 82800 |
|
1,092 |
988 |
$7K |
| ATP18 |
|
1,298 |
944 |
$7K |
| 24640 |
|
12 |
12 |
$7K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
1,638 |
461 |
$6K |
| 0012A |
|
376 |
370 |
$6K |
| 87799 |
|
382 |
350 |
$6K |
| 72132 |
|
484 |
461 |
$6K |
| 36591 |
|
3,847 |
2,750 |
$6K |
| ATP13 |
|
1,304 |
986 |
$6K |
| 51729 |
|
22 |
16 |
$6K |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
82 |
74 |
$6K |
| 83010 |
|
684 |
635 |
$6K |
| 87209 |
|
461 |
418 |
$6K |
| 86696 |
|
476 |
467 |
$6K |
| 84165 |
|
1,293 |
1,169 |
$6K |
| 11045 |
|
19 |
14 |
$5K |
| 73700 |
|
124 |
117 |
$5K |
| 90473 |
|
4,238 |
4,225 |
$5K |
| 80197 |
|
2,257 |
1,165 |
$5K |
| 82977 |
|
1,819 |
1,766 |
$5K |
| 87899 |
|
594 |
571 |
$5K |
| 92555 |
|
346 |
344 |
$5K |
| 70360 |
|
102 |
101 |
$5K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,042 |
426 |
$5K |
| 74740 |
|
25 |
25 |
$5K |
| 90839 |
|
778 |
642 |
$5K |
| 86200 |
|
582 |
573 |
$5K |
| 86308 |
|
1,041 |
1,020 |
$5K |
| 84480 |
|
661 |
639 |
$5K |
| 73060 |
|
830 |
786 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14,787 |
12,920 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
112 |
75 |
$5K |
| 87206 |
|
1,149 |
956 |
$4K |
| G0009 |
Administration of pneumococcal vaccine |
1,961 |
1,908 |
$4K |
| 0011A |
|
385 |
376 |
$4K |
| 87045 |
|
699 |
682 |
$4K |
| 87476 |
|
146 |
144 |
$4K |
| 82951 |
|
388 |
384 |
$4K |
| 87338 |
|
464 |
461 |
$4K |
| 84134 |
|
498 |
423 |
$4K |
| 96376 |
|
25,872 |
14,204 |
$4K |
| ATP16 |
|
765 |
555 |
$4K |
| 86800 |
|
447 |
428 |
$4K |
| 86870 |
|
84 |
74 |
$4K |
| 86039 |
|
527 |
519 |
$4K |
| 89051 |
|
1,056 |
736 |
$4K |
| 51600 |
|
12 |
12 |
$4K |
| 83921 |
|
479 |
473 |
$4K |
| 86364 |
|
872 |
836 |
$4K |
| 95913 |
|
103 |
101 |
$4K |
| 76981 |
|
42 |
42 |
$3K |
| 71101 |
|
117 |
114 |
$3K |
| 92551 |
|
390 |
390 |
$3K |
| 96409 |
|
83 |
52 |
$3K |
| 92610 |
|
38 |
37 |
$3K |
| 92650 |
|
55 |
54 |
$3K |
| 78264 |
|
14 |
14 |
$3K |
| 86617 |
|
285 |
281 |
$3K |
| 82172 |
|
262 |
261 |
$3K |
| 84466 |
|
369 |
361 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,974 |
2,994 |
$3K |
| 84155 |
|
3,214 |
2,964 |
$3K |
| H0046 |
Mental health services, not otherwise specified |
67 |
52 |
$3K |
| 90474 |
|
6,950 |
6,912 |
$3K |
| 87177 |
|
460 |
417 |
$3K |
| 86593 |
|
802 |
789 |
$3K |
| 86255 |
|
320 |
307 |
$3K |
| 86695 |
|
287 |
280 |
$3K |
| 93298 |
|
183 |
181 |
$3K |
| 0134A |
|
84 |
83 |
$3K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
418 |
388 |
$2K |
| 80178 |
|
766 |
711 |
$2K |
| 87449 |
|
418 |
405 |
$2K |
| 94644 |
|
2,829 |
2,614 |
$2K |
| 73660 |
|
70 |
68 |
$2K |
| 87324 |
|
396 |
385 |
$2K |
| 84144 |
|
161 |
152 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
628 |
474 |
$2K |
| 78306 |
|
12 |
12 |
$2K |
| 83521 |
|
421 |
270 |
$2K |
| 88312 |
|
166 |
154 |
$2K |
| 88302 |
|
566 |
533 |
$2K |
| 77470 |
|
13 |
12 |
$2K |
| 80180 |
|
511 |
442 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,163 |
2,330 |
$2K |
| 0081A |
|
66 |
66 |
$2K |
| 85246 |
|
96 |
92 |
$2K |
| 77338 |
|
27 |
25 |
$2K |
| 64494 |
|
80 |
79 |
$2K |
| 74178 |
|
12 |
12 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,835 |
1,400 |
$2K |
| J9045 |
Injection, carboplatin, 50 mg |
597 |
346 |
$2K |
| 96138 |
|
85 |
83 |
$2K |
| 73521 |
|
28 |
28 |
$2K |
| 83525 |
|
235 |
231 |
$2K |
| 94668 |
|
13 |
12 |
$2K |
| 96119 |
|
25 |
25 |
$2K |
| 88300 |
|
763 |
753 |
$2K |
| 96116 |
|
13 |
12 |
$2K |
| 96121 |
|
13 |
12 |
$2K |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$2K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
36 |
24 |
$2K |
| 86147 |
|
79 |
74 |
$2K |
| 90678 |
|
110 |
104 |
$2K |
| 90887 |
|
29 |
27 |
$2K |
| 95911 |
|
12 |
12 |
$2K |
| 72081 |
|
24 |
24 |
$2K |
| 84305 |
|
110 |
109 |
$2K |
| 77001 |
|
17 |
15 |
$2K |
| 92556 |
|
100 |
98 |
$1K |
| 87329 |
|
196 |
193 |
$1K |
| 99397 |
|
149 |
131 |
$1K |
| 87102 |
|
313 |
284 |
$1K |
| 72128 |
|
136 |
129 |
$1K |
| 86225 |
|
197 |
188 |
$1K |
| 51798 |
|
783 |
753 |
$1K |
| 84145 |
|
280 |
253 |
$1K |
| 85245 |
|
61 |
57 |
$1K |
| 80156 |
|
254 |
246 |
$1K |
| 80175 |
|
227 |
221 |
$1K |
| 74175 |
|
53 |
53 |
$1K |
| 97163 |
|
13 |
13 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$1K |
| 93041 |
|
2,577 |
2,078 |
$1K |
| 82952 |
|
389 |
385 |
$1K |
| 82435 |
|
962 |
874 |
$1K |
| 85347 |
|
418 |
403 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
234 |
174 |
$1K |
| 0053A |
|
28 |
28 |
$1K |
| 86709 |
|
143 |
137 |
$1K |
| 85397 |
|
52 |
50 |
$1K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
130 |
104 |
$1K |
| 85651 |
|
453 |
447 |
$1K |
| 90633 |
|
1,810 |
1,810 |
$1K |
| 82677 |
|
56 |
55 |
$981.47 |
| 88313 |
|
240 |
181 |
$979.56 |
| 86336 |
|
66 |
66 |
$972.29 |
| 93321 |
|
2,582 |
2,519 |
$953.94 |
| 0082A |
|
26 |
26 |
$939.36 |
| 94761 |
|
3,089 |
2,425 |
$937.69 |
| 85660 |
|
223 |
217 |
$921.09 |
| 72129 |
|
288 |
275 |
$914.53 |
| 83090 |
|
93 |
93 |
$869.17 |
| 80162 |
|
154 |
140 |
$861.23 |
| 83993 |
|
72 |
69 |
$854.01 |
| 74160 |
|
13 |
13 |
$852.46 |
| J1836 |
Injection, metronidazole, 10 mg |
234 |
183 |
$849.55 |
| 86644 |
|
75 |
63 |
$827.23 |
| 91319 |
|
158 |
158 |
$790.02 |
| 82088 |
|
26 |
26 |
$776.81 |
| 90696 |
|
3,837 |
3,832 |
$753.62 |
| 70310 |
|
444 |
423 |
$747.41 |
| 91305 |
|
2,637 |
2,520 |
$740.96 |
| 83498 |
|
39 |
36 |
$739.73 |
| 93280 |
|
41 |
40 |
$718.62 |
| 82397 |
|
62 |
62 |
$692.23 |
| 84425 |
|
70 |
68 |
$689.91 |
| 0121A |
|
38 |
38 |
$688.05 |
| 91318 |
|
125 |
125 |
$653.60 |
| 0154A |
|
14 |
14 |
$642.18 |
| 84630 |
|
86 |
86 |
$605.02 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
3,127 |
2,547 |
$594.90 |
| 90671 |
|
217 |
216 |
$588.84 |
| 86141 |
|
90 |
89 |
$585.35 |
| 84300 |
|
244 |
227 |
$563.74 |
| 82340 |
|
198 |
188 |
$561.46 |
| 86341 |
|
24 |
15 |
$561.33 |
| 83835 |
|
42 |
38 |
$542.62 |
| 82272 |
|
244 |
232 |
$540.62 |
| ATP19 |
|
127 |
106 |
$513.45 |
| 86300 |
|
42 |
38 |
$511.65 |
| 86146 |
|
19 |
12 |
$496.94 |
| 84402 |
|
24 |
24 |
$488.04 |
| 96136 |
|
13 |
13 |
$466.00 |
| 76000 |
|
30 |
29 |
$431.84 |
| 85240 |
|
27 |
27 |
$431.79 |
| 81596 |
|
47 |
46 |
$428.65 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
160 |
89 |
$424.20 |
| 85613 |
|
69 |
69 |
$420.82 |
| 80299 |
|
55 |
52 |
$409.48 |
| 80230 |
|
12 |
12 |
$408.12 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,944 |
1,863 |
$386.40 |
| 88142 |
|
28 |
28 |
$378.42 |
| 84244 |
|
25 |
25 |
$373.98 |
| 94645 |
|
507 |
473 |
$371.35 |
| 70320 |
|
414 |
348 |
$354.88 |
| 72220 |
|
14 |
14 |
$349.64 |
| 87350 |
|
55 |
55 |
$344.49 |
| 90682 |
|
14 |
14 |
$319.15 |
| 86707 |
|
44 |
44 |
$317.97 |
| 11719 |
|
12 |
12 |
$317.11 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
2,661 |
2,485 |
$307.46 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
187 |
162 |
$299.29 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
16 |
12 |
$297.04 |
| 84154 |
|
41 |
41 |
$292.16 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,048 |
950 |
$283.16 |
| 81050 |
|
205 |
201 |
$266.84 |
| 82103 |
|
26 |
24 |
$259.05 |
| J1940 |
Injection, furosemide, up to 20 mg |
336 |
240 |
$248.97 |
| 93299 |
|
12 |
12 |
$239.62 |
| 89055 |
|
99 |
99 |
$236.92 |
| J9190 |
Injection, fluorouracil, 500 mg |
1,528 |
564 |
$228.37 |
| 86258 |
|
15 |
14 |
$221.52 |
| 93750 |
|
13 |
13 |
$210.62 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
19 |
12 |
$173.80 |
| 82390 |
|
36 |
36 |
$172.04 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,810 |
2,433 |
$171.22 |
| 94010 |
|
18 |
18 |
$170.84 |
| 90620 |
|
16 |
16 |
$170.36 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
194 |
184 |
$164.44 |
| 80185 |
|
57 |
52 |
$159.30 |
| 85384 |
|
30 |
28 |
$158.82 |
| 84432 |
|
12 |
12 |
$156.04 |
| 73000 |
|
15 |
15 |
$154.32 |
| 86301 |
|
39 |
27 |
$146.80 |
| 86335 |
|
12 |
12 |
$142.03 |
| 90685 |
|
2,051 |
2,028 |
$139.83 |
| 82525 |
|
12 |
12 |
$132.30 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
5,520 |
5,159 |
$121.27 |
| 86694 |
|
14 |
13 |
$118.72 |
| 36416 |
|
9,034 |
7,298 |
$113.17 |
| 83930 |
|
45 |
38 |
$107.40 |
| 87101 |
|
14 |
14 |
$105.03 |
| 82360 |
|
15 |
14 |
$102.15 |
| 88360 |
|
14 |
12 |
$100.14 |
| 80183 |
|
13 |
13 |
$95.69 |
| 82375 |
|
13 |
12 |
$94.93 |
| 36410 |
|
41 |
39 |
$81.95 |
| 83935 |
|
34 |
28 |
$81.84 |
| 93282 |
|
12 |
12 |
$76.50 |
| 72020 |
|
25 |
25 |
$70.53 |
| 82787 |
|
13 |
13 |
$64.60 |
| 87106 |
|
13 |
13 |
$53.25 |
| 88311 |
|
82 |
77 |
$51.00 |
| 86063 |
|
14 |
12 |
$35.70 |
| 86008 |
|
35 |
27 |
$32.72 |
| 87176 |
|
14 |
12 |
$32.16 |
| 90710 |
|
4,072 |
4,072 |
$31.84 |
| 94760 |
|
2,791 |
2,664 |
$31.77 |
| 84478 |
|
212 |
140 |
$29.60 |
| ATP20 |
|
14 |
12 |
$25.99 |
| 74022 |
|
13 |
13 |
$25.81 |
| J9267 |
Injection, paclitaxel, 1 mg |
348 |
159 |
$23.13 |
| 90680 |
|
11,137 |
11,102 |
$22.02 |
| 87015 |
|
16 |
12 |
$18.27 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
7,657 |
6,898 |
$13.14 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
3,286 |
2,897 |
$7.14 |
| 91307 |
|
1,384 |
1,261 |
$5.64 |
| C9113 |
Injection, pantoprazole sodium, per vial |
210 |
113 |
$4.99 |
| C1769 |
Guide wire |
4,728 |
4,408 |
$3.58 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
7,156 |
6,328 |
$2.13 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
228 |
181 |
$1.44 |
| 91300 |
|
8,039 |
7,184 |
$0.08 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
3,426 |
2,902 |
$0.08 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
1,652 |
1,530 |
$0.05 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
454 |
421 |
$0.05 |
| 99153 |
Mod sedat endo service >5yrs |
3,210 |
3,043 |
$0.00 |
| 90723 |
|
4,732 |
4,730 |
$0.00 |
| 90744 |
|
1,262 |
1,260 |
$0.00 |
| 90698 |
|
6,756 |
6,743 |
$0.00 |
| 90697 |
|
3,950 |
3,935 |
$0.00 |
| 81511 |
|
184 |
128 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
470 |
449 |
$0.00 |
| 90634 |
|
5,967 |
5,967 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
213 |
210 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
67 |
51 |
$0.00 |
| 91301 |
|
247 |
239 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
259 |
259 |
$0.00 |
| 93320 |
|
179 |
177 |
$0.00 |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
27 |
25 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
42 |
24 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
687 |
666 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
26 |
26 |
$0.00 |
| 91303 |
|
561 |
460 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
38 |
25 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
13 |
12 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
17 |
15 |
$0.00 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
13 |
13 |
$0.00 |
| 90688 |
|
567 |
567 |
$0.00 |
| 91315 |
|
45 |
45 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
12 |
12 |
$0.00 |
| 90381 |
|
24 |
24 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
16 |
14 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
13 |
13 |
$0.00 |
| 91317 |
|
13 |
13 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,494 |
1,439 |
$0.00 |
| J2359 |
Injection, olanzapine, 0.5 mg |
13 |
12 |
$0.00 |
| 99152 |
|
4,009 |
3,814 |
$0.00 |
| 90648 |
|
6,100 |
6,097 |
$0.00 |
| 90700 |
|
1,822 |
1,822 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
132 |
126 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
65 |
38 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
129 |
117 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
31 |
27 |
$0.00 |
| 91312 |
|
2,102 |
2,034 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
33 |
30 |
$0.00 |
| 01992 |
|
78 |
78 |
$0.00 |
| 91313 |
|
82 |
81 |
$0.00 |
| 91308 |
|
185 |
178 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
29 |
26 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
76 |
69 |
$0.00 |
| Q0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg |
37 |
32 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
73 |
70 |
$0.00 |
| 90611 |
|
28 |
27 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
34 |
30 |
$0.00 |
| 76376 |
|
93 |
90 |
$0.00 |
| 77387 |
|
115 |
12 |
$0.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
12 |
12 |
$0.00 |
| 90713 |
|
40 |
40 |
$0.00 |
| C1776 |
Joint device (implantable) |
40 |
40 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
39 |
25 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
13 |
12 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
40 |
26 |
$0.00 |
| J9370 |
Vincristine sulfate, 1 mg |
21 |
12 |
$0.00 |